A pharmaceutical firm concerned with counterfeit products is likely to consider reshoring to reduce the risk of intellectual property theft. The pharmaceutical industry relies heavily on research and development, and the presence of counterfeit products directly affects its intellectual property. Reshoring can help better control the production process and safeguard intellectual property.